Home › Funds › Krensavage Asset Management, LLC › GSK
Krensavage Asset Management, LLC position in GSK
GSK PLC · Health Care
Krensavage Asset Management, LLC reported holding 96,729 shares of GSK (GSK PLC) in its Q2 2026 13F filing — a position valued at US$5.1M, representing 1.93% of its reported portfolio and ranking #12 among its reported holdings. Krensavage Asset Management, LLC has disclosed GSK holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Krensavage Asset Management, LLC's GSK position evolved
Krensavage Asset Management, LLC first disclosed a stake in GSK in Q1 2025 at 272,000 shares (US$10.5M). The position peaked in Q3 2025 at 271,729 shares, worth US$11.7M. Across 6 filings, Krensavage Asset Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 96,729 shares valued at US$5.1M. Notable position changes include a 64% trim in Q4 2025 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 272.00K | $10.54M | New |
| Q2 2025 | 271.73K | $10.43M | Hold |
| Q3 2025 | 271.73K | $11.73M | Hold |
| Q4 2025 | 96.73K | $4.74M | Reduce |
| Q1 2026 | 96.73K | $5.34M | Hold |
| Q2 2026 | 96.73K | $5.07M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GSK and 13F data
GSK (GSK PLC) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GSK
- Dodge & Cox 48.20M sh · $2.53B · Q2 2026
- DODGE & COX 48.20M sh · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.18M sh · $1.32B · Q2 2026
- JTC Employer Solutions Trustee Ltd 8.59M sh · $450.31M · Q2 2026
- Mondrian Investment Partners LTD 4.97M sh · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.60M sh · $188.69M · Q2 2026
- EQUITY INVESTMENT CORP 3.27M sh · $171.40M · Q2 2026
More on Krensavage Asset Management, LLC
FAQ
How long has Krensavage Asset Management, LLC held GSK?
Krensavage Asset Management, LLC has disclosed GSK holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Krensavage Asset Management, LLC's current position in GSK?
As of Q2 2026, Krensavage Asset Management, LLC holds 96.73K shares of GSK (GSK PLC), valued at $5.07M, representing 1.93% of its reported portfolio and ranking #12.
Has Krensavage Asset Management, LLC been buying or selling GSK?
In the latest 13F filing (Q2 2026), Krensavage Asset Management, LLC held unchanged its position in GSK. The position peaked in Q3 2025 at 271.73K shares.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.